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ABSTRACT
Selective mutism (SM) is a diagnosis marked by withdrawal of speech in certain social
situations. The treatment of SM is often a difficult and lengthy process and there are many
barriers to successful intervention. Behavioral therapy is most effective in the treatment of SM
and the addition of therapeutic activities such as games and mobile devices may provide distinct
advantages to this treatment (i.e., decreased patient anxiety levels and more active engagement).
The current investigation examined the utility of mobile applications during the behavioral
treatment of SM as well as the effect of using mobile applications on child-reported and
physiological indicators of anxious responding. Results indicated that children made remarkable
treatment gains in just two treatment sessions (i.e., spoke to the clinician within 22 minutes of
treatment and held five, five-minute conversations with additional adults during a second
session) regardless of modality of delivery (using mobile applications, other activities, or
reinforcement alone). Children shaped to speak with the inclusion of mobile applications
reported less anxiety and exhibited decreased physiological anxious distress during treatment.
The utility of mobile applications during the treatment of SM is discussed in addition to areas for
future research (e.g., mobile-based treatment dissemination initiatives).
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INTRODUCTION
Selective Mutism
Selective Mutism (SM) is a disorder marked by a consistent failure to speak in particular
social situations during which speech is expected (e.g., at school), despite speaking in other
situations (e.g., in the home). Functional impairment in academic or social achievement often
occurs, and is required for the diagnosis according to the Diagnostic and Statistical Manual for
Mental Disorders - Fifth Edition (DSM-5; American Psychiatric Association [APA], 2013). SM
is a rare disorder with a prevalence of less than 1% of the general population (Bergman,
Piacentini, & McCracken, 2002; Chavira, Stein, Bailey, & Stein, 2004; Elizur & Perednik, 2003;
Steinhausen & Juzi, 1996; Viana, Beidel, & Rabian, 2009). SM is diagnosed typically in
childhood and has an average age of onset ranging from 2.7 to 4.1 years (Cunningham, McHolm,
Boyle, & Patel, 2004; Garcia, Freeman, Francis, Miller, & Leonard, 2004).
In the DSM-5, SM was moved from its original placement in the Other Disorders of
Childhood and Adolescence diagnostic category to the Anxiety Disorders category. The rationale
for placement in this category included the many empirical findings that, more often than not,
SM co-occurs with other anxiety disorders (APA, 2013). Of particular interest to researchers has
been the relationship between SM and social anxiety (see Viana et al. 2009, for a review). Due to
the similar clinical presentations of SM and social anxiety disorder (SAD; a disorder
characterized by intense fear and avoidance of social interactions; APA, 2013) it has been
postulated that SM may represent a developmental variant of SAD (Anstendig, 1999; Bergman et
al., 2002; Black & Uhde, 1992; Silveira, Jainer, & Bates, 2004). Some findings suggest that
children with SM report being too afraid to speak in social situations and the lack of speech
represents a behavioral avoidance mechanism (Black & Uhde, 1995; Dummit, Klein, Tancer, &
1

Asche, 1997; Sharp, Sherman, & Gross, 2007; Vecchio & Kearney 2005; Young, Bunnell, &
Beidel, 2012). Further studies supporting the diagnostic overlap include data that approximately
80 to 97% of children with SM also meet diagnostic criteria for SAD (Black & Uhde, 1995;
Young et al., 2012), and relatedly, children with SM report elevated levels of social anxiety and
shyness (Carbone et al., 2010; Cunningham et al., 2004; Dummitt et al., 1997; Steinhausen &
Juzi, 1996). Additional research indicates high familial loadings for anxiety disorders,
particularly social anxiety disorder (Black & Uhde, 1995; Chavira, Shipon-Blum, & Stein, 2005;
Kolvin & Fundudis, 1981; Kristensen & Torgersen, 2001). From an experimental/behavioral
perspective, children with SM often benefit from treatments that reduce social anxiety, both
pharmacological (Black & Uhde, 1994; Harvey & Milne, 1998; Lafferty & Constantino, 1998;
Lehman, 2002; Maskey, 2001; Thomsen, Rasmussen, & Anderson, 1999) and
cognitive/behavioral (see Anstendig, 1998; Cohan, Chavira, & Stein, 2006; Pionek Stone,
Kratochwill, Sladezcek, & Serlin, 2002; Viana et al., 2009 for reviews).
Treatment of Selective Mutism
Treating SM is a difficult and often lengthy process, with some studies reporting
intervention lengths up to six to eight months (e.g., Bergman, Gonzalez, Piacentini, & Keller,
2013; Nolan & Pence, 1970). Treatment barriers include positive and negative reinforcement for
not speaking in certain environments (e.g., Mowrer’s two factor theory; Mowrer, 1947), the
child’s resistance to treatment (Krysanski, 2003), and potentially the child’s reputation or
identity as “the kid who does not talk” (Bunnell & Beidel, 2013). Further, as proposed by
Bunnell and Beidel (2013) “adult attention/pleas to speak often develop a paradoxical behavioral
response from the child (i.e., as the adults plead with the child to speak, that attention may
reinforce lack of speech)” (pp. 292). Difficulty with treatment also may be related to the sparse
2

literature examining the efficacy of treatments for the disorder. The overwhelming majority of
the extant treatment literature in this population consists of case studies and single case designs
whereas there have been only four studies providing group comparisons following treatment
(i.e., Bergman, Gonzalez, Piacentini, & Keller, 2013; Manassis & Tannock, 2008; Oerbeck,
Stein, Wentzel-Larsen, Langsrud, & Kristensen, 2014; Sluckin, Foreman, & Herbert, 1991), and
only two of these investigations included a prospective, randomized control design (i.e.,
Bergman et al., 2013 and Oerbeck et al., 2014). The most recent meta-analysis examining
treatment for SM was published over a decade ago, and supported the use of behavior therapy in
the treatment of SM (Pionek Stone, Kratochwill, Sladezcek, & Serlin, 2002).
The most commonly used interventions for SM include contingency management and
shaping (Amari, Keith, Arlene, Schenick, & Kane, 1999; Bunnell & Beidel, 2013; Facon, Sahiri,
& Riviere, 2008; Marino Fernandez, 1986; Guna-Dumitrescu & Pelletier, 1996; Masten, Stacks,
Caldwell-Colbert, & Jackson, 1996; Nolan & Pence, 1970; Oerbeck, Johansen, Lundahl, &
Kristensen, 2011; Porjes, 1992), stimulus fading (Beare, Torgerson, & Creviston, 2008; Kehle,
Madaus, Baratta, & Bray 1998; Masten, Stacks, Caldwell-Colbert, & Jackson, 1996; Nolan &
Pence, 1970; Oerbeck et al., 2011; Watson & Kramer, 1992), systematic
desensitization/exposure (Bunnell & Beidel, 2013; Kee, Fung, & Ang, 2001; Rasbury, 1974; Rye
& Ullman, 1999; Vecchio & Kearney, 2007; Vecchio & Kearney, 2009), self-modeling (Kehle et
al., 1998), and social skills training (Bunnell & Beidel, 2013; Fisak, Oliveros, & Ehrenreich,
2006; Reuther, Davis, Moree, & Matson, 2011). Contingency management is often the first step
in the treatment process. Rewards are contingent on compliance with directions from the
therapist and parents, such as to produce verbalizations. Over time, rewards become contingent
upon reaching treatment goals of increased difficulty (e.g., speaking at louder volumes or
3

verbalizing words rather than sounds), which may be likened to the rewarding of successive
approximations of speech (i.e., shaping, although in this case “speaking to unfamiliar people” is
the new behavior being learned). Stimulus fading involves the progressive introduction of
additional stimuli (e.g., persons or settings) as the child speaks to someone with whom he or she
is comfortable speaking. Systematic desensitization/exposure therapy is useful particularly when
SM co-occurs with social anxiety. Systematic desensitization involves the presentation of a
mood state (relaxation/enjoyment) incompatible with anxiety when the individual is in the
presence of the anxiety-producing event or situation. Although some efficacy has been
demonstrated when using these interventions separately, increased clinical efficacy may result
when shaping, stimulus fading and exposure are combined.
Comprehensive Intervention for SM and the Use of Activities in Treatment
Many investigations have used a combination of behavioral methods in treating SM.
Often referred to as “modular cognitive-behavioral treatments” or “multidisciplinary
interventions” (e.g., Christon et al., 2012; Giddan, Ross, Sechler, & Becker, 1997), these
interventions have resulted in decreased social anxiety and decreased functional impairment
associated with SM, as well as increased speech production across settings. These
multidisciplinary interventions have varied in delivery, but appear to include common behavioral
methods. Specifically, some success has been noted when using behavioral methods such as
psychoeducation, contingency management, shaping, self-modeling, cognitive restructuring,
relaxation, exposure, systematic desensitization, stimulus generalization/fading, social skills, and
parent training (Bergman et al., 2013; Bunnell & Beidel, 2013; Christon et al., 2012; Giddan et
al., 1997; Guna-Dumitrescu & Pelletier, 1996; Kehle et al., 1998; Mitchell & Kratochwill, 2013;
Powell & Dalley, 1995; Vecchio & Kearney, 2007; Vecchio & Kearney, 2009; Watson &
4

Kramer, 1992).
Careful review of these investigations reveals that an important component of successful
SM intervention may involve the use of devices that prompt vocalization or listening to
previously recorded vocalizations during therapy. Most common among these devices appears to
be the use of audio recorders with which the children record their voices and play it for others to
hear, thus following a desensitization/exposure paradigm (Blum et al., 1998; Kee et al., 2001;
Oerbeck et al., 2011; Oon, 2010). An extension of this paradigm has included the children using
audio devices with pre-recorded responses to answer questions that may be asked by others (e.g.,
“Yes,” “No,” “Thank you,” and “Goodbye”; Kee et al., 2001). Additionally, and following the
desensitization paradigm, the use of games (e.g., chutes and ladders, passing a ball back and
forth, blowing up balloons, and melting ice pops) have been utilized to promote speaking
behaviors during behavior therapy (Mitchell & Kratochwill, 2013; Oon, 2010; Reuther et al.,
2011; Sharkey, McNicholas, Barry, Begley, & Ahern, 2008). Other tools included internet
delivered cognitive behavioral therapy (Fung, Manassis, Kenny, & Fiksenbaum, 2002), index
cards indicating which words to vocalize (Giddan et al., 1997), edited and dubbed video
recordings to simulate the children speaking to others (Kehle et al., 1998), and a car radio where
sound was increased in volume to require the child to speak at increased voice volumes (Nolan &
Pence, 1970). The use of activities in behavioral intervention for SM has provided an interesting
treatment paradigm that, when coupled with today’s technology, may provide an important
advancement in the treatment of SM. One of these activities may include the use of mobile
applications.
Using Mobile Applications to Treat Selective Mutism
Mobile devices such as tablet PCs and smartphones provide numerous free-to-use and
5

inexpensive applications, which are downloadable to the device. By having a virtually unlimited
number of activities (e.g., games requiring verbalization, sound and video recorders, flash cards
decibel meters, recording devices) in one compact electronic device, mobile devices may serve
as an invaluable tool during the initial stages of treating SM. Further, many youth are familiar
with and readily use mobile devices on a daily basis (Lenhart, 2015; Madden, Lenhart, Duggan,
Cotesi, & Gasser, 2013). Thus, the use of mobile devices may promote both more engagement
and a willingness to participate in treatment in addition to providing a range of electronic
activities in one compact device.
Thus far, mobile applications have been used in one study (i.e., Bunnell & Beidel, 2013).
This investigation resulted in the successful treatment of a 17-year-old female with SM who was
previously unresponsive to pharmacological and standard behavioral intervention. Following
limited treatment gains using traditional exposure therapy alone, the authors used mobile
applications while rewarding successive approximations of speech. Using mobile applications
and a shaping hierarchy, the patient was speaking in a conversational tone and using complete
sentences at the end of the first treatment session. These results required replication. In Study 1
we used a single case design strategy to replicate and validate the use of mobile applications as
an adjunct to behavior therapy.
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STUDY 1: REPLICATION AND EXTENSION
The primary goal of Study 1 was to replicate and extend the initial treatment success
(Bunnell & Beidel, 2013) using a single-case design strategy. Specifically, the primary
dependent variable in Study 1 was the time until audible speech occurred. The hypotheses for
Study 1 were as follows: following initiation of treatment using mobile applications, children
will a) speak audibly during the initial treatment session to at least one unfamiliar adult (i.e., the
clinician) and b) speak audibly to the clinician and at least one other unfamiliar adult during the
second treatment session.
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METHOD
Procedure
Following informed consent, children were assessed via a clinician administered
diagnostic interview in addition to child- and parent-report measures to affirm the diagnosis of
SM. Children and their parents were informed that the purpose of the study would be to evaluate
the usefulness of mobile applications during the treatment of SM, and that they would play
games on a tablet PC (i.e., an Apple iPad) with the goal of helping them to feel more comfortable
speaking around other people. In addition to one treatment planning session, children completed
two, 55-minute sessions conducted in the same week. This investigation focused solely on the
ability of the mobile applications to quickly shape speaking behavior. All assessment and
treatment sessions were administered by a senior doctoral student in clinical psychology.
Design
Study 1 used a single-case (A-B) design strategy, the results of which are interpreted
graphically. This design compares baseline data to data collected following the implementation
of treatment to determine a treatment effect via the demonstration of a clear change from
baseline. In Study 1, the treatment planning session served as a baseline for the assessment of
speech to unfamiliar adults. In addition, subjective anxiety was assessed during baseline as well
as the treatment sessions.
Participants
Participants were four children who met DSM-5 (APA, 2013) criteria for SM. Children
ranged in age from 6- to 10-years. Children 1 and 2 were Latina female sisters (ages 9 and 10years, respectively) who had not spoken to non-family members since 5-years of age. Both
children refused speech to peers and staff at school, and reported elevated levels of social anxiety
8

as the reason for their withdrawal of speech. Child 3 was a 7-year old Latino male who refused
speech to non-family members since 4-years of age, with the exception of whispers to one
teacher and one peer approximately twice per week. Although his mother perceived him as
experiencing elevated levels of social anxiety, Child 3 did not report significant elevations in
anxiety as the reason for his speech withdrawal. Child 4 was a 7-year old Caucasian female who
refused speech to non-family members since 3-years of age, with the exception of whispers to
one peer at school approximately once per day. All children refused speech to extended family
members within and outside of their home. Exclusionary criteria included potential comorbid
severe psychopathology (i.e., bi-polar disorder, schizophrenia) and/or suicidal ideation. Children
with other co-morbid diagnoses were not excluded and none of the children were taking antidepressant medications during the time of the study. See Table 1 for participant demographics
and child- and parent-reported assessment results.
Table 1 Participant Demographic and Assessment Data
Child
Age
Sex
Race
SPAI-C
SPAIC-PV
1
9
F
Latino
37
33
2
10
F
Latino
35
31
3
7
M
Latino
2
24
4
7
F
Caucasian
23
26
Note. SPAI-C = Social Phobia and Anxiety Inventory for Children; SPAIC-PV = Social Phobia
and Anxiety Inventory for Children – Parent Version; Scores ≥ 18 on the SPAI-C and SPAIC-PV
reflect clinically elevated levels of social anxiety.
Assessment
Diagnostic interview. The Anxiety Disorders Interview Schedule for DSM-IV: Child
and Parent Versions (ADIS-C/P; Silverman and Albano, 1996) are semi-structured interviews
used for the diagnosis of anxiety and related disorders in youth. The ADIS-C/P provides a
diagnosis based on both child- and parent-report, although the assessment of child functioning
relied mostly on parent-report in the current study. If children responded to questions during the
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interview, it was by nodding their head.
Child social anxiety. Children and their parents completed the Social Phobia and
Anxiety Inventory for Children (SPAI-C; Beidel, Turner, & Morris, 1995) and the SPAI-C
Parent Version (SPAIC-PV; Beidel, Turner, & Morris, 2004). The SPAI-C and SPAIC-PV
consist of 26 items that assess the frequency of anxiety symptoms during particular social
situations. Participants rate each item using three ordered responses: 0 = Never, or Hardly Ever,
1 = Sometimes, and 2 = Most of the Time or Always. The SPAI-C and SPAIC-PV have
demonstrated adequate reliability and validity (Beidel et al., 1995; Beidel, Turner, Hamlin, &
Morris, 2000; Higa, Fernandez, & Nakamura, 2006)
Behavioral Assessment. Children’s within-session speaking behaviors and anxiety were
recorded digitally by the clinician. The number of persons to whom the children spoke during
each session as well as the children’s latency to speak to the clinician and additional adults was
recorded digitally and counted. Children were prompted to rate their current anxiety level on a 5point Likert-scale (0 = No Anxiety; 1 = Mild Anxiety; 2 = Moderate Anxiety; 3 = Severe
Anxiety; 4 = Extreme Anxiety) every ten minutes during baseline and both treatment sessions.
Treatment
Following assessment, children and their parents participated in a treatment planning
session during which the treatment rationale was presented, and a contingency management plan
to increase speaking behaviors was established. Specifically, children were told that they would
earn $10 of monopoly money to spend on prizes for each compliant response during sessions.
Further, children would receive rewards from their parents (e.g., extra dessert, staying up 30minutes past bedtime) following each treatment session during which they complied with
clinician requests.
10

Children then completed two, 55-minute sessions administered within the same week.
During session 1, children were rewarded for successive approximations of speech while using
mobile applications. During the second session children were rewarded for approaching and
speaking to multiple other unknown adults around the University campus, which consisted
mostly of asking open-ended questions. All children followed the same shaping hierarchy,
including the same mobile applications at each step in treatment, with some minor variation
during the second session (see Table 2 for the specific shaping hierarchy).
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Table 2 Mobile Applications Used During Each Session
Session

Step

Mobile Application

Behavior to Emit

Treatment Goal

1

1

Free Candle

Blow out candle once

Emit audible sound

2

Free Candle

Blow out candle with increased pressure

Emit audible sound at increased volume

3

Free Candle

Blow out candle at increased frequency (≤5)

Emit multiple audible sounds at increased volume

4

Blowing Game

Blow ants off of a virtual picnic table loudly

Emit multiple audible sounds at increased volume

5

Yes/No Fun Deck

Blow in response to close-ended questions

Emit audible sounds while responding to questions

6

Talking Gina

Blow “O” sounds

Begin to emit audible verbalizations

7

Talking Gina

Blow “U” sounds

Continue to emit audible verbalizations

8

Talking Gina

Blow vowel sounds

Increase the number of audible verbalizations

9

Meet the Vowels

Whisper vowels

Continue to practice emitting audible verbalizations

10

Meet the Letters

Whisper letters including consonants

Increase the number of audible verbalizations

11

Meet the Words

Whisper words

Begin to verbalize words

12

Meet the Words

Speak words with increased volume

Increase the volume of verbalized words

13

Camstar

Say the names of items photographed

Generalize speaking to items rather than written words

14

Yes/No Fun Deck

Say yes or no to questions asked

Respond verbally to close-ended questions

15

Monsters

Record and play responses to open ended questions

Respond verbally to open-ended questions

16

Monsters

Verbalize questions for others to answer

1

Monsters*

--

SPLDecibel Meter

Record and play open ended questions asked by the
child directed toward therapist
Record and play open ended questions asked by the
child directed toward others in the room
Ask open ended questions while maintaining a
designated volume

2

Verbalize questions for others to answer
Verbalize questions for others to answer at increased
volume

Note. * = Possible substitution of SPLDecibel Meter application depending on the child’s progress.
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RESULTS
Behavioral Assessment
Within-session speaking. Figure 1 displays the number of adults to whom each child
spoke during each session. All children withheld speech during the treatment planning session.
All children spoke to the clinician during the first session, and child 3 spoke to six adults in
addition to the clinician during the first session. As displayed in Figure 1, children spoke to a
range of 7 to 19 adults during the second session (M = 13). This number depended on the
availability of adults with whom children could speak as well as the time allotted for each
session, but of note is that children approached and spoke with all adults with whom they were
instructed to initiate conversation.
20
18

Number of Adults

16
14

Child 1

12

Child 2

10

Child 3

8

Child 4

6

4
2
0
Treatment Planning

Session 1
Session Number

Session 2

Figure 1 Number of Adults Spoken to During Each Session
Within-session latency to speak. As demonstrated in Table 3, all children whispered to
the clinician within 31 minutes of the first session and all children spoke in a conversational tone
within 40 minutes of the first session. Further, all children spoke to an adult other than the
clinician within 14 minutes of the second session.
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Table 3 Within-Session Latency to Speak
Child
Session 1
Session 2
Time to Whisper to
Time to Speak Audibly to
Time to Speak to an
Clinician
Clinician
Additional Adult
Child 1
30.00
40.06
13.44
Child 2
31.20
39.38
12.53
Child 3
19.29
27.39
*
Child 4
19.97
32.30
5.00
Note. * = Child 3 spoke to an additional unfamiliar adult within 50 minutes of the first session;
time is measured in minutes.
Within-session anxiety. As demonstrated in Figure 2, all children reported mild to
moderate levels of anxiety during the first two sessions, with the exception of child 3 who
reported ratings of 0 for both sessions.

Child 2

4
3
2
1
0

Anxiety

Anxiety

Child 1
4
3
2
1
0

Time During the Session

Time During the Session

Child 4

4
3
2
1
0

Anxiety

Anxiety

Child 3

Time During the Session

4
3
2
1
0

Time During the Session

Figure 2 Within-Session Anxiety Ratings
 = Session 1;  = Session 2
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DISCUSSION
The goal of Study 1 was to determine whether the use of mobile applications during the
shaping of verbal behaviors could enhance verbal responding in children with SM. When
compared to the extant literature and clinical experience, the results of Study 1 suggest that,
when used in conjunction with rewarding successive approximations of speech, the use of mobile
applications may decrease the time and clinical effort necessary to achieve a significant
milestone in the treatment of children with SM, that is, to achieve the goal of speaking to a nonfamily member in a public setting. All children spoke to an unfamiliar adult (i.e., the clinician)
during the first treatment session. All children spoke to the clinician audibly within 40 minutes of
the first treatment session. All children also spoke audibly to the clinician and at least one other
unfamiliar adult during the second treatment session (children spoke to an average of 13 adults
during this session) and did so within the first 14 minutes of the second treatment session. These
rapid treatment gains are highly encouraging given that children in this study had not spoken to
unfamiliar adults or peers before beginning treatment.
There are limitations of Study 1; predominantly a lack of comparison to children treated
using the identical shaping protocol but without the use of mobile applications. Another
limitation not addressed in Study 1, but which might be addressed in an additional investigation
is a lack of understanding of the exact mechanisms by which the changes occurred. More
specifically, it is unknown why such rapid treatment gains were made during this study. It is
possible that the engagement of the mobile device served to decrease the child’s anxiety allowing
them to more fully engage in the shaping process (Bunnell & Beidel, 2013). The authors
suggested that “using tasks that require vocalization but engage children in reinforcing game-like
activities may shift direct focus away from speaking, which in turn could decrease social anxiety
15

and thereby allow speech to occur” (pp. 292). In other words, it is possible that reciprocal
inhibition, the process that underlies desensitization (Wolpe, 1954, 1958, 1961; Wolpe &
Lazarus, 1966), may allow for faster treatment gains in children with SM. This explanation
seems likely given the minimal anxiety reported by the children during these initial sessions.
Anecdotally, when asked why they were not anxious, all children reported, “because I was
having fun”. It may be possible to test this hypothesis by examining children’s physiological
anxious arousal during treatment using mobile applications, while comparing this reactivity to
children who are treated using the same method but without the inclusion of mobile applications.
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STUDY 2: MECHANISMS OF CHANGE DURING TREATMENT: INTRODUCTION
Systematic Desensitization
Systematic desensitization was one of the earliest behavioral interventions for anxiety
disorders, particularly specific phobias (Wolpe, 1954, 1958, 1961; Wolpe & Lazarus, 1966).
According to Wolpe, systematic desensitization involves the use of a competing response that
interferes with a response pattern which is considered “unadaptive”. Theoretically, unadaptive
responses (e.g., anxiety) are eliminated through use of the counter conditioning paradigm (Jones,
1924), which postulates that a conditioned stimulus’ ability to elicit a conditioned response is
lost if the conditioned stimulus is paired with a new stimulus that elicits a response incompatible
with the original conditioned response. For this process to occur, the incompatible response must
be “stronger” than the original conditioned response (Wolpe, 1968). The pairing of this
incompatible response is believed to inhibit the original conditioned response, which is
weakened over time. Because of the bi-directionality of each stimulus’ ability to inhibit the other,
Wolpe termed this process “conditioned inhibition based upon reciprocal inhibition” (Wolpe,
1968). Based on these laboratory findings Wolpe introduced the intervention known as
systematic desensitization, which involves the gradual exposure to feared stimuli while
simultaneously conditioning a response that is incompatible with fear (e.g., typically relaxation
or feelings of happiness). This differs from other types of exposure therapy, which are based on
an extinction model and involve the use of exposure to feared stimuli without the use of a
competing response. Systematic desensitization is used widely in the treatment of anxiety
disorders.
In theory, a systematic desensitization/reciprocal inhibition paradigm might explain the
rapid treatment gains observed when using the mobile applications. Pairing an emotion
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incompatible with anxiety during a distressful situation (i.e., interaction with a stranger) will
eliminate fearful responses in those settings, which in turn should allow speech to occur. Based
on the minimal levels of child-reported anxiety observed in these two studies, this seems likely,
but confounds arise when using solely child-reported anxiety (e.g.,). Adding the direct
assessment of anxious arousal during treatment using measures such as heart rate variability
(HRV; i.e., inter-beat interval) and electrodermal activity (EDA; also known as galvanic skin
conductance) would help to clarify the mechanism by which mobile applications seem to exert
their effect, particularly by comparing autonomic arousal to that of children treated with behavior
therapy (i.e., without the use of mobile applications).
HRV is the variation between heart beats (i.e., the inter-beat-interval), and is an indicator
of autonomic regulation or flexibility (i.e., the interplay between sympathetic and
parasympathetic activation; Billman, 2011). Increases in HRV occur when individuals are in a
calm or relaxed state, which is indicative of increased parasympathetic activity. Conversely,
decreases in HRV are observed when an individual is experiencing high levels of distress such
that parasympathetic activity is inhibited (e.g., a “fight or flight” response). These trends have
been noted particularly as individuals attempt to regulate their emotions during stressful social
interactions (Porges, 2007). Similarly, EDA is a direct measure of sympathetic activation and
elevations in EDA are observed in youths with elevated social anxiety during socially-distressing
interactions (e.g., Mesa, Beidel, & Bunnell, 2014).
Thus, the goal of Study 2 is to examine children’s physiological arousal during shaping
procedures, with and without the use of mobile applications. The hypotheses of Study 2 were
that, when compared to children shaped with reinforcement alone and children shaped using
other therapeutic activities, children shaped with the use of mobile applications would a)
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complete the shaping hierarchy earlier in the session, b) speak earlier in the session, c) report
lower levels of anxiety during treatment, and d) exhibit lower levels of physiological anxious
arousal (as measured by HRV and EDA).
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METHOD
Procedure
Following informed consent and assent, children and their parents participated in a
diagnostic assessment and completed questionnaires assessing child- and parent-report of social
anxiety. Children were informed that the purpose of the study would be to help them to feel more
comfortable speaking around other people. Children and their parents were also educated on the
use of physiological monitoring equipment, the rationale behind the procedure, and contingency
management procedures which included rewards of $10 of monopoly money for each compliant
response during sessions to be spent on prizes at the end of the session in addition to rewards
from parents between sessions. Children were then assigned randomly to one of three behavioral
therapy groups: children shaped to emit audible speech including the use of mobile (i.e., Apple
iPad) applications (iBT), children shaped using other similar activities (aBT), or children shaped
with reinforcement alone (BT). A Microsoft Excel formula for random number generation was
use to assign children to their respective groups. Following assessment and randomization,
children participated in two sessions, conducted within the same week. Physiological arousal was
assessed during these sessions. Outcome data included children’s time to completion of the
shaping hierarchy, latency to speak to the clinician and an additional adult, self-reported anxiety,
and physiological measures of anxious arousal (as measured by HRV and EDA). Assessment and
treatment sessions were administered by two senior doctoral students in clinical psychology, and
sessions were video and audio-recorded.
Design
Study 2 used a single case (A-B) design with comparisons of child speaking behaviors,
self-reported anxiety, and physiological anxious arousal among the iBT, aBT and BT groups.
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Children were asked to sit quietly for five minutes at the beginning of each session to establish a
baseline level of anxious arousal during both treatment sessions. Following this baseline phase,
the treatment phase began and data collection continued.
Participants
Participants included 15 (n = 5 per group) children who met DSM-5 (APA, 2013) criteria
for SM. Participants ranged in age from 5 to 17 years. Exclusionary criteria included children
with severe psychopathology (i.e., bi-polar disorder, schizophrenia) and/or suicidal ideation.
Participants with other co-morbid diagnoses were not excluded. Participants taking antidepressant medications during the time of the study were included as long as they had been on a
stable dose for at least one month prior to beginning treatment. It should be noted that Child 5 in
the BT group presented with a unique case of SM and SAD such that her withdrawal of speech
and social fears were specific to speaking to adults, particularly while in the presence of her
parents, thus her scores on the SPAI-C and SPAIC-PV both fell below the cutoff for a probable
diagnosis of SAD. Despite this, the child and her parents insisted that social anxiety was the
driving factor behind her withdrawal of speech. Similarly, Child 2 in the iBT group reported low
levels of social anxiety on the SPAI-C, although his parents felt that his lack of speech was
largely associated with social anxiety, as demonstrated by his elevated SPAIC-PV score.
Participant demographic, diagnostic, and social anxiety severity data are presented in Table 4.
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Table 4 Participant Demographic, Diagnostic, and Social Anxiety Severity Data
Age Sex
Race
Diagnoses
SPAI-C
SPAIC-PV
iBT Group
Child 1
9
M
White
SM, SAD
23
14
Child 2
16
M
White
SM, SAD, SepAnx
9
40
Child 3
13
F
White
SM, SAD
41
33
Child 4
9
F
White
SM, SAD, GAD
38
43
Child 5
6
F
Latina
SM, SAD
16
16
aBT Group
Child 1
10
F
White
SM, SAD
41
38
Child 2
5
M
Latino
SM, SAD
46
46
Child 3
16
F
Latina
SM, SAD
28
43
Child 4
11
F
White
SM, SAD
39
42
Child 5
5
F
Latina
SM, SAD, Enuresis
38
36
BT Group
Child 1
15
F
Latina
SM, SAD
44
45
Child 2
5
M
Black
SM, SAD, SepAnx
36
40
Child 3
8
M
White
SM, SAD, Enuresis
30
28
Child 4
7
F
White
SM, SAD
30
41
Child 5
9
F
White
SM, SAD
13
14
Note. SM = Selective Mutism; SAD = Social Anxiety Disorder; SepAnx = Separation Anxiety
Disorder; GAD = Generalized Anxiety Disorder; iBT = group shaped using mobile applications;
aBT = group shaped using other therapeutic activities; BT = groups shaped using no activities;
SPAI-C = Social Phobia and Anxiety Inventory for Children; SPAIC-PV = Social Phobia and
Anxiety Inventory for Children – Parent Version; Scores ≥ 18 on the SPAI-C and SPAIC-PV
reflect clinically elevated levels of social anxiety.
Assessment
Diagnostic interview. The ADIS-C/P was administered to children and their parents
simultaneously. Children were not asked to speak during this interview although they were asked
to nod their heads (yes or no) to indicate whether they agreed with their parents’ response to
particular questions. If disagreements took place, children would whisper to their parent and
child and parent would compromise on an appropriate response. Children did not speak to the
clinician during the assessment session.
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Child and parent report of social anxiety. Children and their parents completed the
SPAI-C and SPAIC-PV. For younger children who experienced difficulty with reading, parents
assisted in reading SPAI-C questions.
Behavioral assessment. Each child’s latency to complete the shaping hierarchy during
the first session, and latency to speak to the clinician and an additional unfamiliar adult (during
the second session) was recorded and coded using the Noldus Behavioral Observation System
XT (Noldus Information Technology, 2015) and comparisons were made amongst groups.
Children reported their current level of anxiety using a 5-point Likert scale following the
baseline period and every five minutes during sessions.
Physiological assessment of anxious arousal. Physiological anxious arousal (i.e., HRV
and EDA) was measured using the Mindware BioLab Acquisition Software and Ambulatory
System (Mindware Technologies, LTD, 2009). This ambulatory equipment allows for the
simultaneous collection of data continuously (i.e., approximately 500 samples per second) via a
small ambulatory unit, which transmits data wirelessly to be stored digitally for subsequent
analysis. These data are then examined juxtaposed to a synced video recording of the treatment
sessions using the Noldus Behavioral Observation System XT (Noldus Information Technology,
2015). Anxious arousal relative to baseline levels was then calculated and compared amongst
groups.
Treatment
All children were shaped using the hierarchy described in Table 5 with the iBT group
including the use of mobile applications (see column 3), the aBT group including the use of other
activities which were similar to each step’s respective mobile application (e.g., bubbles,
pinwheels, flash cards, sound recorders; see column 4), and the BT group following the
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hierarchy without the inclusion of activities or devices (see column 5). Children remained in the
session until completion of the hierarchy. In two cases (i.e., iBT Child 3 and aBT Child 2) this
was not possible due to variable consistency in the children’s level of response to requests from
the clinician, and the eventual withdrawal of compliant responses. Thus, data from these two
children were not analyzed. Children were rewarded with $10 of monopoly money for each
compliant response during sessions. This monopoly money was added at the end of the session
and spent on prizes (e.g., small toys and stickers) at the clinic, and also counted toward a reward
from the child’s parent following the session (e.g., money towards a game or toy). They were
rewarded for successive approximations of speech during the first session, and were required to
complete each step of the hierarchy successfully a minimum of five times to advance to the next
step. The protocol for the second session included five, five-minute conversations with
unfamiliar adults during which children were rewarded each time they spoke to the adult. During
this process, children asked the adult an open-ended question, which the adult answered, and
then asked the same question to the child. This process continued, alternating between the adult
and the child initiating the initial questions for a total of five minutes. During session 2, children
in the iBT and aBT groups began with the use of the mobile device or voice recorder (see Table
5), but were allowed to continue conversations without the use of the device if they felt
comfortable doing so.
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Table 5 Shaping Hierarchy for Study 2
Session

Step

1

1

Mobile
Application
Free Candle

2

2

Other Tool

Behavior to Emit

Treatment Goal

Blow Bubbles

Blow once

Emit audible sound

Free Candle

Blow Bubbles

Blow with increased pressure

Emit audible sound at increased volume

3

Free Candle

Blow Bubbles

Blow at increased frequency (≤5)

Emit multiple audible sounds at increased volume

4

Blowing Game

Pinwheel

Blow loudly and repeatedly

Emit multiple audible sounds at increased volume

5

Yes/No Fun Deck

Yes/No Flashcards

6

Talking Gina

Voice Recorder

Blow in response to close-ended
questions
Blow “O” sounds

Emit audible sounds while responding to
questions
Begin to emit audible verbalizations

7

Talking Gina

Voice Recorder

Blow “U” sounds

Continue to emit audible verbalizations

8

Talking Gina

Voice Recorder

Blow vowel sounds

Increase the number of audible verbalizations

9

Meet the Vowels

Flash Cards

Whisper vowels

10

Meet the Letters

Flash Cards

Whisper letters including consonants

Continue to practice emitting audible
verbalizations
Increase the number of audible verbalizations

11

Meet the Words

Flash Cards

Whisper words

Begin to verbalize words

12

Meet the Words

Flash Cards

Verbalize words with increased volume

Increase the volume of verbalized words

13

Camstar

Disposable Camera

Say the names of items photographed

14

Yes/No Fun Deck

Yes/No Flashcards

Say yes or no to questions asked

Generalize speaking to items rather than written
words
Respond verbally to close-ended questions

15

Monsters

Voice Recorder

Respond to open ended questions

Respond verbally to open-ended questions

16

Monsters

Voice Recorder

Verbalize questions for others to answer

1

Monsters

Voice Recorder

Ask and respond to open ended
questions
Ask and respond to open ended
questions with additional adults

Verbalize questions for others to answer

Note. Children were required to complete each step of the hierarchy a minimum of 5 times before moving to the next step.
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RESULTS
Data Analysis
Session recordings and physiological data were imported into Noldus Observer XT
observation software (Noldus Information Technology, 2015). Baseline and treatment phases
were coded as well as time until completion of the shaping hierarchy, children’s latency to speak
to the clinician (operationalized as either whispering or saying a complete word), and latency to
speak to an additional unfamiliar adult. These data were then compared descriptively among
groups. Children’s self-reported anxiety was recorded in-session by the clinician and change
scores were calculated by averaging scores across the treatment phase and subtracting this
average from baseline ratings. Children’s anxiety ratings at the time of first speech to the
clinician were also recorded and compared among groups. HRV (i.e., inter-beat interval) and
EDA (i.e., skin conductance level in microsiemens) were averaged for each minute of each
session.
Small n Statistics software (Gilroy, 2015) was used to compare baseline and treatment
HRV and EDA data for each participant using the following evidence-based metrics for single
case research. The Percentage of All Non-Overlapping Data statistic (PAND; Parker, HaganBurke, & Vannest, 2007) measures the percentage of all data points that do not overlap between
baseline and treatment. Hedge’s g* (Hedges, 1981) is an effect size measure with additional
adjustment for the upward bias of smaller sample sizes (i.e., does not assume equal variances).
Pearson’s r2 represents the variance accounted for by the relation between baseline and treatment
phase scores.

26

Behavioral Assessment
Hierarchy completion and speaking behavior. Thirteen of 15 children (86.67%)
completed the shaping hierarchy during the first session. Children’s latency to complete the
hierarchy ranged from 14 to 54 minutes (M = 31.21, SD = 12.62). The average latency to
complete the hierarchy for children in the iBT group (M = 27.69, SD = 6.84) was approximately
3 to 7 minutes shorter in comparison to those in the aBT (M = 35.65, SD = 9.23) and BT (M =
31.79, SD = 17.82) groups, respectively.
All children, regardless of group spoke to the clinician within 22 minutes of the first
session. The average latency to speak to the clinician for all groups fell between 10.56 and 13.68
minutes, a range of approximately three minutes. This latency was slightly higher for children in
the iBT group. All children spoke to an additional unfamiliar adult within 97.76 seconds of being
prompted to do so during the second session. The average latency for each group ranged from
23.43 to 36.09 seconds. All children participated in the planned five, five-minute conversations
with unfamiliar adults (see Table 6).
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Table 6 Behavioral Assessment of Hierarchy Completion and Speaking Behavior
Latency to Speak to
Latency to Hierarchy
Latency to Speak to the
Additional Adult
Completion (in minutes)
Clinician (in minutes)
During Second Session
(in seconds)
iBT Group
Child 1
37.81
22.05
11. 80
Child 2
25.86
13.48
14.54
Child 3
Child 4
23.55
5.04
20.29
Child 5
23.53
14.15
97.76
M (SD)
27.69 (6.84)
13.68 (6.98)
36.09 (46.48)
aBT Group
Child 1
37.36
11.23
18.35
Child 2
Child 3
22.32
8.18
44.05
Child 4
39.52
11.00
73.47
Child 5
43.40
16.05
3.77
M (SD)
35.65 (9.23)
11.61 (3.27)
34.91 (30.63)
BT Group
Child 1
54.19
10.80
13.75
Child 2
47.35
20.08
29.59
Child 3
19.02
6.95
25.06
Child 4
23.99
8.83
23.86
Child 5
14.41
6.17
24.89
M (SD)
31.79 (17.82)
10.56 (5.61)
23.43 (5.84)
Note. M = Mean; SD = Standard Deviation.
Child-reported anxiety. With respect to self-reported levels of anxiety, children in the
iBT group tended to report lower and less varied ratings of anxiety for both sessions. The
average rating during the first session for children in this group was 1.57 (SD = 0.74), compared
to 2.67 (SD = 0.89) and 2.20 (SD = 1.22) for the aBT and BT groups, respectively. The average
rating during the second session for children in the iBT group was 1.46 (SD = 0.60), compared to
2.54 (SD = 1.30) and 1.64 (SD = 1.12) for the aBT and BT groups, respectively. All children in
the iBT group reported moderate and below moderate levels of anxiety (≤ 3), whereas children in
the aBT and BT groups reported maximum ratings between 4 and 5.
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With respect to individual ratings of anxiety, four children (two in the aBT group and two
in the BT group) reported anxiety ratings above baseline levels during the first session. Children
in the iBT group did not report ratings above their initial baseline anxiety ratings during this
session, suggesting no increase in anxiety as a result of treatment demands to begin speaking.
During session 2, a similar pattern was observed with the exception that one child in the iBT
group reported ratings above baseline, although it should be noted that the child from this group
was the only child to return back to baseline levels by the end of the session.
Children’s anxiety ratings during each session were averaged and subtracted from
baseline anxiety ratings, with positive and negative values indicating average increases and
decrease from baseline, respectively. One child in the aBT group and one child in the BT group
exhibited average increases in anxiety from baseline during session 1. In contrast, all other
children exhibited either average decreases or no average change in anxiety from baseline. On
average, each group exhibited mean decreases in anxiety from baseline, with the iBT group
demonstrating the largest decrease, and the aBT and BT groups following in suit. Group
differences were minor but followed the hypothesized pattern of anxious responding (see Figure
3).
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Figure 3 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 1
In contrast to session 1, average decreases in anxiety from baseline were not observed for
session 2. Only one child in the iBT group exhibited an average increase from baseline, whereas
two children from the aBt and BT groups exhibited increases. On average, each group exhibited
mean increases in anxiety from baseline. A similar pattern to session 1 was observed such that
the iBT group demonstrated the smallest average increase with the aBT and BT groups following
in suit. Group differences were more pronounced for this session and once again followed the
hypothesized pattern of anxious responding (see Figure 4).
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Figure 4 Average Self-Reported Anxiety Ratings in Relation to Baseline Ratings for Session 2
Anxiety ratings were recorded at the time of each child’s first audible word to the
clinician during the first session. As demonstrated in Figure 5, following initial speech to the
clinician, children in the iBT group reported the lowest ratings of anxiety (M = 1.5, SD = 0.58) in
comparison to the aBT (M = 2.5, SD = 0.58) and BT (M = 2.2, SD = 1.30) groups.
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Figure 5 Self-Reported Anxiety Following Initial Speech
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Physiological assessment of anxious arousal. Comparisons of HRV among children in
the three treatment groups followed similar patterns to self-report of anxiety, yet comparisons of
EDA and did not yield consistent results for groups across sessions.
HRV Session 1. Results of analyses of HRV concurred with self-reported anxiety.
Specifically, children in the iBT group tended to exhibit fewer changes in HRV from baseline.
From baseline measures, mean HRV decreased by 0.51 and 0.92 standard deviations for children
in the aBT and BT groups, respectively, indicating increased sympathetic (i.e., “fight or flight”)
responding. Conversely, children in the iBT group showed average 0.05 standard deviation
increase in HRV from baseline, indicating parasympathetic activation (e.g., recovery after a
“fight or flight” response). Non-overlap effect size indices concurred with these results with
children in the iBT group demonstrating the least non-overlap in HRV between baseline and
treatment phases (i.e., 66.10% vs. 83.80% and 72.65% for the aBT and BT groups, respectively).
The iBT group’s change in HRV from baseline also accounted for a smaller proportion of the
variance (i.e., less 8% to 11% compared to the other groups; see Table 7).
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Table 7 Comparisons in HRV among Participants for Session 1
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
744.24 (46.76)
759.22 (21.17)
-0.30
Child 2
1193.64 (69.59) 1068.21 (115.70)
-1.02
Child 3
Child 4
728.16 (84.89)
703.14 (45.46)
0.28
Child 5
658.81 (30.22)
618.70 (24.72)
1.23
Mean
818.68 (40.23)
799.86 (69.39)
0.05
aBT Group
Child 1
677.24 (17.80)
645.32 (26.86)
-1.10
Child 2
Child 3
684.01 (21.08)
706.30 (38.22)
0.55
Child 4
925.97 (17.04)
851.31 (32.37)
-2.15
Child 5
611.28 (10.67)
629.26 (24.84)
0.67
Mean
724.63 (16.65)
708.05 (30.57)
-0.51
BT Group
Child 1
836.44 (31.94)
794.18 (45.10)
-0.86
Child 2
702.64 (17.17)
717.53 (32.10)
0.43
Child 3
674.08 (10.84)
658.76 (18.00)
-0.81
Child 4
576.14 (14.32)
515.90 (18.06)
-3.09
Child 5
671.98 (17.99)
663.31 (29.90)
-0.28
Mean
692.26 (18.45)
669.94 (28.65)
-0.92
Note. PAND = percentage of all non-overlapping data.

PAND

r2

56.25
87.88
37.50
82.76
66.10

0.03
0.25
0.02
0.33
0.16

85.18
75.86
95.74
78.43
83.80

0.28
0.09
0.60
0.13
0.27

60.00
67.27
74.07
100.00
61.90
72.65

0.19
0.05
0.18
0.76
0.02
0.24

HRV Session 2. Children in the iBT group demonstrated the least non-overlap in HRV
between baseline and treatment phases (i.e., 59.35% vs. 70.00% and 81.83% for the aBT and BT
groups, respectively), suggesting the least change from baseline for this group during session 2.
However, the results of the Hedge’s g* effect size estimates suggested that the aBT group
exhibited the smallest decrease in HRV (Hedge’s g* = -0.29), followed by the iBT (Hedge’s g*
= -0.78), and BT (Hedge’s g* = -1.05) groups. Little difference was noted for the variance
accounted for changes in HRV from baseline between the iBT and aBT groups (r2s = 0.17 and
0.19, respectively), although the BT group’s change from baseline accounted for a large portion
of the variance (r2 = 0.44; see Table 8).
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Table 8 Comparisons in HRV among Participants for Session 2
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
815.53 (24.43)
777.05 (36.14)
-0.99
Child 2
1011.93 (66.49)
980.17 (43.61)
-0.61
Child 3
Child 4
725.54 (40.36)
685.97 (28.37)
-1.18
Child 5
700.69 (6.86)
691.66 (24.92)
-0.35
Mean
813.42 (34.53)
783.71 (33.26)
-0.78
aBT Group
Child 1
678.74 (9.07)
661.94 (10.34)
-1.49
Child 2
Child 3
698.09 (21.64)
685.18 (22.19)
-0.53
Child 4
827.52 (22.28)
820.76 (32.90)
-0.19
Child 5
584.36 (9.34)
598.02 (12.00)
1.05
Mean
697.18 (15.58)
691.47 (19.36)
-0.29
BT Group
Child 1
953.50 (13.81)
892.02 (22.98)
-2.50
Child 2
676.86 (24.60)
715.32 (33.48)
1.07
Child 3
697.68 (31.51)
660.70 (16.63)
-1.80
Child 4
583.71 (25.37)
553.41 (11.59)
-1.91
Child 5
738.74 (25.05)
719.70 (15.79)
-0.10
Mean
730.10 (24.07)
708.23 (20.09)
-1.05
Note. PAND = percentage of all non-overlapping data.

PAND

r2

63.89
47.06
70.59
55.88
59.35

0.24
0.11
0.31
0.04
0.17

79.41
73.68
57.50
69.44
70.00

0.42
0.08
0.01
0.26
0.19

97.56
75.00
88.89
94.77
52.94
81.83

0.67
0.27
0.51
0.54
0.24
0.44

EDA Session 1. Results of analyses of EDA for session 1 were mixed. Children in the
iBT group demonstrated the least non-overlap in EDA between baseline and treatment phases
(i.e., 86.46% vs. 91.10% and 99.26% for the aBT and BT groups, respectively), suggesting the
smallest increase from baseline for this group. The results of the Hedge’s g* effect size estimates
suggested that the aBT group exhibited the smallest increase in EDA (Hedge’s g* = 2.96),
followed by the iBT (Hedge’s g* = 3.25), and BT (Hedge’s g* = 4.11) groups. The variance
accounted for in changes in EDA from baseline followed a similar pattern (see Table 9). Overall,
the iBT and aBT groups appeared most similar in response with respect to EDA, with the BT
group consistently exhibiting the highest level of physiological response.
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Table 9 Comparisons in EDA among Participants for Session 1
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
17.91 (1.40)
19.40 (1.06)
1.23
Child 2
4.02 (0.13)
6.51 (0.42)
5.66
Child 3
Child 4
2.67 (0.14)
6.39 (0.95)
3.75
Child 5
5.60 (0.82)
9.58 (1.59)
2.36
Mean
7.55 (0.62)
10.47 (1.00)
3.25
aBT Group
Child 1
4.80 (0.74)
6.60 (1.15)
1.45
Child 2
Child 3
5.45 (0.53)
6.37 (0.95)
1.73
Child 4
8.04 (3.27)
17.5 (1.14)
5.85
Child 5
9.90 (0.60)
12.64 (0.89)
2.83
Mean
7.05 (1.28)
10.78 (1.03)
2.96
BT Group
Child 1
6.70 (1.19)
14.44 (1.32)
5.30
Child 2
7.17 (0.65)
11.90 (1.61)
2.73
Child 3
11.43 (1.30)
14.57 (0.77)
3.23
Child 4
13.42 (0.55)
15.96 (0.58)
3.98
Child 5
12.73 (0.36)
15.05 (0.40)
5.31
Mean
10.29 (.81)
14.38 (0.93)
4.11
Note. PAND = percentage of all non-overlapping data.

PAND

r2

45.83
100.00
100.00
100.00
86.46

0.32
0.91
0.82
0.64
0.67

87.04
79.31
100.00
98.04
91.10

0.40
0.22
0.91
0.72
0.56

100.00
100.00
96.29
100.00
100.00
99.26

0.90
0.92
0.77
0.84
0.90
0.86

EDA Session 2. Changes in EDA for the second session were inconclusive with all
children exhibiting elevated levels of physiological responding. No overlap in levels of EDA
between baseline and treatment phases were observed. An opposite pattern from previous
analyses was observed such that children in the iBT group exhibited the largest increase in EDA,
followed by the aBT and BT groups in sequentially decreasing order. These results contrasted
results from HRV analyses as well as child-report of anxious responding (see Table 10).
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Table 10 Comparisons in EDA among Participants for Session 2
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
8.80 (0.88)
13.99 (0.35)
10.41
Child 2
6.15 (0.13)
7.910 (0.27)
6.16
Child 3
Child 4
7.97 (2.10)
20.31 (1.58)
6.73
Child 5
5.60 (0.82)
9.58 (1.59)
2.36
Mean
7.13 (0.98)
12.94 (0.95)
6.41
aBT Group
Child 1
5.21 (0.40)
8.10 (0.45)
5.89
Child 2
Child 3
4.28 (0.67)
6.92 (0.61)
3.86
Child 4
9.79 (1.00)
19.95 (0.93)
7.85
Child 5
12.39 (1.67)
19.20 (0.79)
6.54
Mean
7.92 (0.93)
13.54 (0.69)
6.03
BT Group
Child 1
4.90 (1.14)
12.81 (2.62)
2.84
Child 2
11.4 (0.51)
20.14 (1.80)
4.63
Child 3
12.73 (0.64)
16.93 (0.38)
9.11
Child 4
7.99 (1.06)
11.72 (1.03)
3.24
Child 5
7.82 (0.62)
11.25 (1.13)
2.85
Mean
8.97 (0.79)
14.57 (1.39)
4.53
Note. PAND = percentage of all non-overlapping data.
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PAND

r2

100.00
100.00
100.00
100.00
100.00

0.97
0.92
0.94
0.64
0.87

100.00
100.00
100.00
100.00
100.00

0.92
0.83
0.95
0.93
0.90

100.00
100.00
100.00
100.00
100.00
100.00

0.72
0.87
0.96
0.77
0.72
0.81

DISCUSSION
Traditionally, the treatment of SM has been a difficult and lengthy process. This may, in
part, be due to the many barriers to treatment commonly observed within this population (e.g.,
reinforcement for not speaking in certain environments and children’s resistance to treatment).
Behavioral intervention for SM, including contingency management, shaping, systematic
desensitization and exposure, has evidenced the most empirical support based on meta-analytic
review (Pionek Stone et al., 2002). Data suggest that the addition of therapeutic activities (e.g.,
games, sound recorders) also may provide some advantages to the behavioral treatment of SM,
particularly when coupled with today’s technological advances (e.g., mobile devices such as
tablet PCs and smartphones; Bunnell & Beidel, 2013; Bunnell, Procci, Beidel, & Bowers, in
press). Particularly, mobile devices allow access to a wide variety of mobile applications (e.g.,
games requiring verbalization, sound and video recorders, flash cards decibel meters, recording
devices) that may provide therapeutic value for the treatment of SM in one small, convenient
location. In addition to convenience and applicability, the use of mobile devices may promote
both more engagement and a willingness to participate in treatment, perhaps through systematic
desensitization/reciprocal inhibition (Wolpe, 1968); specifically, the pairing of enjoyment or
pleasure, rather than anxiety or fear, when speaking with a stranger.
The results of Study 2 largely supported the hypotheses. With respect to hierarchy
completion of speaking behaviors during treatment, the results of Study 1 were replicated.
Children in the iBT group completed the hierarchy earlier that children in the aBT and BT
groups, although this difference was minor (i.e., their latency to complete the hierarchy was 3 to
7 minutes longer in length). All children, regardless of group, spoke to the clinician within 22
minutes of treatment. Examination of group differences revealed that the BT group demonstrated
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the shortest latency to speak to the clinician, followed sequentially by the aBT and iBT groups,
respectively. Perusal of session recordings revealed that this minor difference in latency was
likely due to time spent switching between and setting up mobile applications/therapeutic
activities as well as time spent providing instructions for each application/activity. For example,
the average time spent instructing children in the first step in the hierarchy was 14.46 seconds for
the BT group, whereas instruction time was 41.56 and 46.96 seconds for the aBT and iBT
groups, respectively. Hypothetically, multiplying this instruction time for each of the nine
changes in mobile applications/therapeutic activities would result in approximately 6 and 9
minutes of additional instruction time throughout the protocol for the aBT and iBT groups,
respectively. Regardless of possible group differences, it is important to note that these
differences are not likely to have clinical significance, especially given that the largest mean
difference between groups for speaking to the clinician was approximately 3 minutes. All
children also completed five, five-minute conversations with additional unfamiliar adults during
the second treatment session. After being prompted to do so, all children began speaking initially
to an unfamiliar adult within approximately 1.5 minutes. The average latency to speak to an
additional adult was similar between groups.
To our knowledge, no other study has reported the elicitation of speech within the first
session of the treatment of SM for multiple children, particularly across such a wide age range.
Moreover, this is the first investigation to report speech to multiple unfamiliar adults during the
second session of treatment. Although requiring replication with a larger sample, perhaps if used
initially in combination with other recent interventions for SM (e.g., Bergman et al. 2013, and
Oerbeck et al. 2014), more rapid treatment progress might occur, allowing ultimately for a
shorter length of treatment and higher cost-effectiveness. These data support the prior literature
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(e.g., Cohan et al., 2006; Pionek Stone et al., 2002) suggesting that behavioral strategies are most
effective in the treatment of SM, and demonstrate specifically that the use of a structured shaping
hierarchy and specific contingency management protocol may result in early verbalization. This
may, perhaps, occur regardless of the activities with which they are administered, although
understanding the specific mechanisms of change during treatment is of great importance
(Kazdin & Nock, 2003).
The outcome of this investigation supported the second hypothesis. In particular, children
in the iBT group consistently reported lower and less variable levels of anxiety during each
session when compared to children in the other groups. Their maximum rating of anxiety fell
within the moderate range (≤ 3), whereas some children in the other two groups reported ratings
in the severe and extreme ranges. Consistent patterns also were observed for children’s average
anxiety ratings in relation to baseline ratings such that children in the iBT group indicated
smaller changes in distress in both sessions when compared to children in the other groups. This
pattern also held true when examining children’s report of anxiety following initial speech to the
clinician (i.e., children in the iBT group reported lower levels of distress after speaking to the
clinician for the first time). These data were consistent with those observed in Study 1, and
suggest that children’s subjective experience of anxious responding during treatment is
decreased when mobile applications are used, as opposed to other therapeutic activities and
reinforcement alone.
Given SM’s recent reclassification as an anxiety disorder in the DSM-5 (APA, 2013), and
literature suggesting that SM may be a developmental variant of SAD (e.g., Anstendig, 1999;
Bergman et al., 2002; Black & Uhde, 1992; Silveira et al., 2004), finding ways to engage these
children in therapy using a treatment modality that promotes speech while eliciting limited
39

subjective anxious distress is of great importance. Granted, not all children with SM meet criteria
for SAD, some might be better classified as anxious-communication delayed or anxious-mildly
oppositional (Cohan, Chavira, Shipon-Blum, Hitchcock, Roesch, & Stein, 2008), and others
might simply be exhibiting oppositional behaviors (although these findings are mixed; Viana et
al., 2009). Despite debate over etiology and co-morbidity of the disorder, it is plausible that a
structured and outlined shaping hierarchy and specific contingency management protocol that
makes use of tools that cause little to no distress in these children may be of particular use as
treatments for SM are further refined.
The final hypothesis was that children in the iBT group would exhibit lower levels of
physiological anxious arousal in comparison to children in other groups. The data from the first
session supported this hypothesis as children in the iBT group demonstrated an average standard
deviation increase in HRV from baseline and the least non-overlap in HRV between baseline and
treatment phases, whereas standard deviation decreases and higher non-overlap in HRV were
noted in the aBT and BT groups. These data suggest greater regulation of anxious arousal in
children in the iBT group when compared to children in the other groups. These results were
partially supported by the finding that children in the iBT group once again demonstrated the
least non-overlap between baseline and treatment phases in EDA, although effect size changes
between baseline and treatment phases suggested some variation in responding.
Physiological data for the second session provided varied results, which presented some
difficulty in interpretation. Specifically, children in the iBT group demonstrated the least nonoverlap between baseline and treatment phases for levels of HRV, but no variation in nonoverlap between phases was observed for EDA among children, regardless of group. Effect size
indices did not concur with these findings and varied depending on the physiological measure
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used (i.e., HRV vs. EDA). For example, effect size results suggested that children in the aBT
group exhibited the smallest decrease in HRV relative to baseline, whereas other results
suggested that children in the BT group exhibited the smallest increase in EDA during session 2.
Despite somewhat mixed results, particularly in the case of EDA data, collectively the
data suggest decreased anxious responding in the iBT group. A number of factors might explain
some of the more ambiguous findings in this study. One factor might have been that children had
the option of continued use of mobile applications or voice recorders during session 2 based on
their preference, which might have led to changes in physiological anxious arousal. More
saliently, EDA is associated with numerous emotional response patterns. These include negative
emotions such as fear, anxiety and embarrassment, but also include positive emotions such as
amusement, happiness, and pleasure (Kreibig, 2010). Given this confound, it may be difficult to
differentiate between anxious and pleasurable responding (i.e., either due to enjoyment from
activity or positively reinforcing stimuli) in these children based solely on EDA response. To
illustrate, children using mobile applications might have experienced pleasure, resulting in
elevated EDA levels, whereas children shaped with reinforcement alone might have experienced
higher levels of anxious distress, also resulting in elevated levels of EDA. Despite this confound,
self-reported anxious distress and HRV data suggested that children experience less anxious
distress when mobile applications are included, at least during initial administration of the
shaping hierarchy.
The examination of HRV in addition to child-reported anxiety in this study is a particular
strength as it allows for a more specific analysis of anxious responding, particularly in relation to
social anxiety or distress (Porges, 2007). Specifically, the average effect size increase in HRV
during shaping of speech for the iBT group suggests increased parasympathetic activity, or
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plainly put, a recovery after a “fight or flight” response. These data provide initial support for the
postulation that shaping of speech with the inclusion of mobile applications can be an effective
strategy in working with children with SM, and that the likely mechanism of change in this
process is counter conditioning. Moreover, although the results of this study suggest that children
with SM respond similarly with respect to hierarchy completion and speaking behavior
regardless of modality of delivery, there may be benefits for the clinician to use mobile
applications in this process. For instance, having numerous therapeutic activities in one small,
compact device might be particularly advantageous, especially as “digital technologies play an
important role in young children’s lives, and they generally embraced them with enthusiasm and
pleasure” (Chaudron, 2015; pp. 24). Further, mobile devices are likely to be readily available to
clinicians across a wide range of settings (i.e., recent data suggest that approximately 78% of
college graduates own smartphones; Smith, 2015). Perhaps the most clinically significant finding
relates to rapid treatment gains observed as a result of using this particular shaping hierarchy,
and data suggesting the experience of less distress while including the use of mobile
applications. Given the commonly reported lengthy treatment requirements for SM, having an
established procedure for reinforcing speech early in the treatment process will be of great value,
especially during the beginning stages of treatment.
This study has several limitations that provide opportunities for future work in this area.
First, this study made use of a single case design strategy with a randomized assignment to
treatment groups. Although this design was appropriate for the question at hand, a larger
randomized controlled trial would allow for more powerful statistical comparisons. The small
sample included in this study limited the ability to test group differences statistically. Difficulty
with recruitment in this population is well noted with published investigations examining the
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treatment of SM traditionally having included small samples (e.g., N = 21 and 24 for Bergman et
al. 2013 and Oerbeck et al. 2014, respectively). Difficulty with recruiting this population is likely
due to the low prevalence of the disorder (i.e., ≤ 1%). A second limitation which might have
affected data from the second session was that children had the option to continue use of mobile
applications or voice recorders based on their preference. While some children chose to continue
using these devices, others did not, which limited consistency for this session. Third, it should be
clearly noted that the protocol presented in this study is not intended as a comprehensive
treatment for SM. The shaping hierarchy provided should be viewed as a useful tool during the
initial stages of the treatment of SM; to promote speech early in treatment in hopes of decreasing
the time needed to begin to make initial therapeutic gains. Further intervention is needed past
these two sessions, as speaking to a clinician is unlikely to result in spontaneous speech in the
child’s natural environment. As noted by Beidel and Turner (2007), after children with SM and
SAD are able to consistently produce speech following behavioral shaping of verbalizations,
they may then go on to successfully participate in continued evidence-based intervention for
SAD (e.g., Social Effectiveness Therapy; Turner, Beidel, Cooley, Woody, & Messer, 1994)
which aims to decrease social anxiety and increase the frequency and effectiveness of
socialization. Fourth, no follow-up data were collected, thus it is unclear if the rapid initiation of
speech was maintained weeks later.
In summary, rewarding successive approximations of speech using this shaping hierarchy
is likely to lead to early speech production for children with SM, regardless of the modality in
which it is delivered. Children’s experience of anxiety may be lessened with the use of
therapeutic activities such as mobile applications and other fun games, as evidenced by
children’s report of anxious distress and physiological data in concordance with this report. It is
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evident that mobile applications provide some utility during the treatment of SM. Further, it is
possible that mobile devices will demonstrate incremental utility as efforts are made to increase
the reach and accessibility of evidence-based procedures for encouraging speech in these
children. This reach is not likely to be limited to providers, as protocols such as the one
described in this investigation might be used by parents and teachers, following adequate
training, to promote generalization of speaking behaviors to the child’s natural environment.
Future research efforts in the area of technology and the treatment of SM might focus on this
initiative as the potential reach will be widened significantly. In truth, we are only beginning to
understand the utility and potential of today’s technological advances to increase the quality of
mental health care, and future research in this area is likely to lead to surprising advances in this
effort.
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Table 11 Comparisons in HR among Participants for Session 1
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
79.07 (2.19)
80.96 (5.59)
0.31
Child 2
50.40 (3.04)
56.95 (7.68)
0.81
Child 3
Child 4
85.62 (5.58)
83.32 (8.30)
-0.26
Child 5
97.10 (4.02)
91.25 (4.18)
-1.27
Mean
78.05 (3.71)
78.12 (6.44)
-0.10
aBT Group
Child 1
88.64 (2.31)
93.13 (3.76)
1.1
Child 2
Child 3
87.78 (2.72)
85.21 (5.02)
-0.49
Child 4
64.81 (1.20)
70.58 (2.72)
1.99
Child 5
98.18 (1.71)
95.50 (3.98)
-0.63
Mean
84.85 (1.98)
86.10 (3.87)
0.49
BT Group
Child 1
71.81 (2.71)
78.80 (4.50)
0.82
Child 2
85.43 (2.12)
83.79 (3.86)
-0.39
Child 3
89.03 (1.42)
91.14 (2.51)
0.81
Child 4
104.19 (2.55)
116.44 (4.16)
2.79
Child 5
89.34 (2.44)
90.63 (4.07)
0.31
Mean
87.96 (2.45)
92.16 (3.82)
0.87
Note. PAND = percentage of all non-overlapping data.
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PAND

r2

56.25
87.88

0.03
0.18

-

-

37.5
82.76

0.02
0.35

66.10

0.14

85.18

0.28

-

-

75.86
95.74
78.43

0.07
0.56
0.11

83.80

0.25

60
67.27
74.07
100
61.9

0.17
0.05
0.18
0.72
0.03

72.65

0.23

Table 12 Comparisons in HR among Participants for Session 2
M (SD)Baseline
M (SD)Treatment
Hedge’s g*
iBT Group
Child 1
73.62 (2.21)
77.38 (3.75)
0.94
Child 2
59.50 (3.91)
61.33 (2.86)
0.55
Child 3
Child 4
82.90 (4.56)
87.61 (3.55)
1.15
Child 5
85.63 (0.83)
86.85 (3.11)
0.37
Mean
75.41 (2.88)
78.29 (3.32)
0.75
aBT Group
Child 1
88.41 (1.17)
90.66 (1.42)
1.46
Child 2
Child 3
86.01 (2.77)
87.66 (2.87)
0.55
Child 4
72.55 (1.93)
73.22 (2.93)
0.21
Child 5
102.70 (1.64)
100.37 (1.99)
-1.07
Mean
87.42 (1.88)
87.98 (2.31)
0.29
BT Group
Child 1
62.93 (0.92)
67.30 (1.75)
2.34
Child 2
88.74 (3.18)
84.06 (4.12)
-1.05
Child 3
86.14 (3.95)
90.87 (2.27)
1.72
Child 4
102.94 (4.29)
108.46 (2.30)
1.87
Child 5
81.29 (2.72)
83.41 (1.84)
0.96
Mean
84.41 (3.01)
86.82 (2.45)
1.17
Note. PAND = percentage of all non-overlapping data.
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PAND

r2

63.89
47.06

0.22
0.09

-

-

70.59
55.88

0.3
0.04

59.35

0.16

79.41

0.41

-

-

75.86
57.5
69.44

0.09
0.01
0.27

70.55

0.19

97.56
75
88.89
94.77
52.94

0.64
0.26
0.49
0.53
0.23

81.83

0.43
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